Breaking News on Global Pharmaceutical Technology & Manufacturing

AAPS 2012 in Chicago breezed into Chicago, the windy city, for the American Association of Pharmaceutical Scientists' (AAPS) annual conference. We spoke with some of the drug industry's thought leaders and tracked down all the breaking news.

News from AAPS

Xcelience plans EU clinical trial supply expansion after opening new US plant

23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.

News from AAPS

Low API and excipient volumes vital to win authorisation under EU PIP says EMA

23-Oct-2012 - Pharmas should use lower API and excipient volumes if seeking authorisation under the EU Paediatric Investigation Plan  (PIP) says the EMA.

update - audio available

Catalent says sharing with industry will not dull competetive edge

22-Oct-2012 - Catalent says making its technology available to industry will not affect its competitive edge.

News in brief

Catalent aims to boost drug delivery through industry-academia partnership

18-Oct-2012 - Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

Disptaches from AAPS

Eliminate scale up by using R&D equipment for commercial production: GSK

18-Oct-2012 - Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.

Dispatches from AAPS

Capsugel expands liquid fill capsule capabilities

17-Oct-2012 - Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.

Dispatches from AAPS

Bend Research hunting new partnerships to boost bioavailability offering

17-Oct-2012 - Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

Dispatches from AAPS

Remember regional Biosimilar regs and ref drugs differ, says Pfizer

16-Oct-2012 - Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.

Dispatches from AAPS

Emerging market CMOs and their customers must make info easily available: FDA

16-Oct-2012 - Make information about generic production readily available when working with vendors in emerging markets for quicker US approval, says the FDA.

Dispatches from AAPS

Peru's GMP requirements mean delayed approvals, says expert

16-Oct-2012 - Stricter GMP requirements in Peru are increasing the time it takes to get drugs approved and may not be giving regulators any useful additional information. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...